Photodynamic Therapy with Verteporfin for Choroidal Neovascularization of Pathologic Myopia in Japanese Patients: Comparison with Nontreated Controls
- 17 December 2007
- journal article
- research article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 145 (3), 518-526.e1
- https://doi.org/10.1016/j.ajo.2007.10.032
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Intravitreal injection of bevacizumab for choroidal neovascularisation associated with pathological myopiaBritish Journal of Ophthalmology, 2007
- Photodynamic Therapy for Nonsubfoveal Choroidal Neovascularization in 100 Eyes With Pathologic MyopiaAmerican Journal of Ophthalmology, 2007
- Retinal pigment epithelium changes after photodynamic therapy for choroidal neovascularization in pathological myopiaActa Ophthalmologica Scandinavica, 2006
- PHOTODYNAMIC THERAPY WITH VERTEPORFIN FOR SUBFOVEAL CHOROIDAL NEOVASCULARIZATION SECONDARY TO PATHOLOGIC MYOPIARetina, 2006
- Time Course and Morphology of Vascular Effects Associated with Photodynamic TherapyOphthalmology, 2005
- Choroidal neovascularisation in pathological myopia: an update in managementBritish Journal of Ophthalmology, 2005
- Choroidal Neovascularization in Pathologic Myopia: Three-Year Results After Photodynamic TherapyAmerican Journal of Ophthalmology, 2005
- Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization secondary to pathologic myopia—1-year results of a prospective seriesEye, 2004
- Prognostic factors influencing visual outcome of photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopiaAmerican Journal of Ophthalmology, 2004
- Japanese age-related macular degeneration trial: 1-year results of photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degenerationAmerican Journal of Ophthalmology, 2003